Skip to content
Tenfell
Awarded contract
Published 27 Apr 2023

NHS National Generics Pharmaceuticals - Dasatinib and Paliperidone Injection

NHS England · London

Key facts

Awarded
27 Mar 2023
Contract starts
30 Apr 2023
Contract ends
31 Jan 2025
Procedure
Open procedure (above threshold)
Buyer type
Central government

Awarded to 5 suppliers

SupplierValue
Janssen-Cilag Ltd—
Teva UK Ltd—
Mylan—
Zentiva Pharma UK Ltd—
Mercury Pharmaceuticals Limited—

Description

Invitation to offer for NHS National Generic Pharmaceuticals - Dasatinib and Paliperidone Injection

Offer reference number: CM/PHG/22/5694 FIND A TENDER (FTS) - 2023/S 000-001392 Period of framework agreement: The total maximum duration of the framework agreement to be no more than 21 months with an option or options to extend (at the Authority's discretion) for a period or periods up to a total of 48 months. Potential periods of call-offs under the framework agreement:

CM/PHG/22/5694/00 - Dasatinib CESW 01/05/2023 - 30/04/2024 - (12 Months) LSNE 01/05/2023 - 30/04/2024 - (12 Months) NWLN 01/05/2023 - 30/04/2024 - (12 Months)

CM/PHG/22/5694/01 - Paliperidone Injection: LSNE 01/05/2023 - 31/05/2024 (13 Months) NWLN 01/05/2023 - 31/01/2025 (21 months)

Categories (CPV)

Similar open tenders

About NHS England

Their tenders, awards, contracts coming up for renewal, decision makers and committee papers.

View buyer profile

Their other open tenders

Published by the buyer on Contracts Finder archive (Open Contracting) (Open Government Licence v3.0). Always read the original notice before responding.